Recombinant interleukin-11 for chemotherapy-induced thrombocytopenia

Med Lett Drugs Ther. 1998 Jul 31;40(1032):77-8.
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic
  • Fees, Pharmaceutical
  • Humans
  • Injections, Subcutaneous
  • Interleukin-11 / administration & dosage
  • Interleukin-11 / blood
  • Interleukin-11 / therapeutic use*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / blood
  • Recombinant Proteins / therapeutic use
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / drug therapy*

Substances

  • Antineoplastic Agents
  • Interleukin-11
  • Recombinant Proteins
  • oprelvekin